NCT02684019View on ClinicalTrials.gov

Goal Directed Propofol Sedation With Magnesium Sulphate Versus Dexmedetomidine for ERCP Procedure

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions
Lack of Drug Action
Interventions
DRUG

Dexmedetomidine

added to propofol sedation

DRUG

Magnesium Sulphate

added to propofol sedation

Trial Locations (1)

11221

Theodor Bilharz Research Institute, Giza

All Listed Sponsors
lead

Theodor Bilharz Research Institute

OTHER

NCT02684019 - Goal Directed Propofol Sedation With Magnesium Sulphate Versus Dexmedetomidine for ERCP Procedure | Biotech Hunter | Biotech Hunter